多囊卵巢综合征患者的月经周期与胰岛素抵抗的关系
Relationship between Menstrual Cycle and Insulin Resistance in Patients with Polycystic Ovary Syndrome
DOI: 10.12677/ACM.2024.143691, PDF,   
作者: 张晓宇, 林 琳*:新疆医科大学第一附属医院妇科,新疆 乌鲁木齐
关键词: 多囊卵巢综合征月经周期胰岛素抵抗Polycystic Ovary Syndrome Menstrual Cycle Insulin Resistance
摘要: 育龄期妇女多囊卵巢综合征的患病率约6%~20%,是一种常见的生殖内分泌代谢疾病。胰岛素抵抗和月经周期紊乱是多囊卵巢综合征的特征,50%~70%多囊卵巢综合征患者有胰岛素抵抗,月经周期异常是多囊卵巢综合征患者诊断的必要条件,多达85%的多囊卵巢综合征患者早期表现出明显的月经周期异常。最近几年来,有研究结果表明,多囊卵巢综合征患者月经周期与胰岛素抵抗相关,本文主要对多囊卵巢综合征患者的月经周期与胰岛素抵抗的关系进行综述。
Abstract: The prevalence of polycystic ovary syndrome in women of reproductive age is about 6%~20%, which is a common reproductive endocrine metabolic disease. Insulin resistance and menstrual cy-cle disorder are the characteristics of polycystic ovary syndrome. 50%~70% of polycystic ovary syndrome patients have insulin resistance. Abnormal menstrual cycle is the necessary condition for the diagnosis of polycystic ovary syndrome, and up to 85% of patients with polycystic ovary syn-drome show significant early menstrual cycle abnormalities. In recent years, some studies have shown that the menstrual cycle of polycystic ovary syndrome patients is associated with insulin re-sistance. This article reviews the relationship between the menstrual cycle and insulin resistance in polycystic ovary syndrome patients.
文章引用:张晓宇, 林琳. 多囊卵巢综合征患者的月经周期与胰岛素抵抗的关系[J]. 临床医学进展, 2024, 14(3): 241-245. https://doi.org/10.12677/ACM.2024.143691

参考文献

[1] Jahromi, B.N., Borzou, N., Parsanezhad, M.E., et al. (2021) Associations of Insulin Resistance, Sex Hormone-Binding Globulin, Triglyceride, and Hormonal Profiles in Polycystic Ovary Syndrome: A Cross-Sectional Study. International Journal of Reproductive Biomedicine, 19, 653-662.
[2] Harris, H.R., Titus, L.J., Cramer, D.W., et al. (2017) Long and Irregular Menstrual Cycles, Polycystic Ovary Syndrome, and Ovarian Cancer Risk in a Population-Based Case-Control Study. International Journal of Cancer, 140, 285-291. [Google Scholar] [CrossRef] [PubMed]
[3] Abraham Gnanadass, S., Divakar Prabhu, Y. and Valsala Gopalakrishnan, A. (2021) Association of Metabolic and Inflammatory Markers with Polycystic Ovarian Syndrome (PCOS): An Update. Archives of Gynecology and Obstetrics, 303, 631-643. [Google Scholar] [CrossRef] [PubMed]
[4] Ding, H., Zhang, J., Zhang, F., et al. (2021) Resistance to the Insulin and Elevated Level of Androgen: A Major Cause of Polycys-tic Ovary Syndrome. Frontiers in Endocrinology, 12, Article 741764. [Google Scholar] [CrossRef] [PubMed]
[5] Wang, Y.X., Shan, Z., Arvizu, M., et al. (2020) Associations of Menstrual Cycle Characteristics across the Reproductive Life Span and Lifestyle Factors with Risk of Type 2 Diabetes. JAMA Network Open, 3, e2027928. [Google Scholar] [CrossRef] [PubMed]
[6] Hussein, K. and Karami, M. (2023) Association be-tween Insulin Resistance and Abnormal Menstrual Cycle in Saudi Females with Polycystic Ovary Syndrome. Saudi Pharmaceutical Journal, 31, 1104-1108. [Google Scholar] [CrossRef] [PubMed]
[7] Niu, J., Lu, M. and Liu, B. (2023) Association between Insulin Re-sistance and Abnormal Menstrual Cycle in Chinese Patients with Polycystic Ovary Syndrome. Journal of Ovarian Re-search, 16, Article No. 45. [Google Scholar] [CrossRef] [PubMed]
[8] Li, X., Yang, D., Pan, P., et al. (2022) The Degree of Menstrual Disturbance Is Associated with the Severity of Insulin Resistance in PCOS. Frontiers in Endocrinology, 13, Article 873726. [Google Scholar] [CrossRef] [PubMed]
[9] Li, X., Zhu, Q., Wang, W., et al. (2019) Elevated Chemerin Induces Insulin Resistance in Human Granulosa-Lutein Cells from Polycystic Ovary Syndrome Patients. FASEB Journal, 33, 11303-11313. [Google Scholar] [CrossRef
[10] Zhang, C., Hu, J., Wang, W., et al. (2020) HMGB1-Induced Aberrant Autophagy Contributes to Insulin Resistance in Granulosa Cells in PCOS. FASEB Journal, 34, 9563-9574. [Google Scholar] [CrossRef
[11] Stener-Victorin, E. and Deng, Q. (2021) Epigenetic Inheritance of Polycystic Ovary Syndrome—Challenges and Opportunities for Treatment. Nature Reviews Endocrinology, 17, 521-533. [Google Scholar] [CrossRef] [PubMed]
[12] Kamrul-Hasan, A., Aalpona, F.T.Z. and Selim, S. (2021) Clinical, Metabolic and Hormonal Profiles of Bangladeshi Adolescents with Polycystic Ovary Syndrome. Touch Reviews in En-docrinology, 17, 54-58. [Google Scholar] [CrossRef
[13] Ezeh, U., Ezeh, C., Pisarska, M.D., et al. (2021) Menstrual Dys-function in Polycystic Ovary Syndrome: Association with Dynamic State Insulin Resistance Rather than Hyperandro-genism. Fertility and Sterility, 115, 1557-1568. [Google Scholar] [CrossRef] [PubMed]
[14] Ezeh, U., Pisarska, M.D. and AndAzziz, R. (2022) Associa-tion of Severity of Menstrual Dysfunction with Hyperinsulinemia and Dysglycemia in Polycystic Ovary Syndrome. Human Reproduction, 37, 553-564. [Google Scholar] [CrossRef] [PubMed]
[15] Liao, B., Qi, X., Yun, C., et al. (2022) Effects of Androgen Ex-cess-Related Metabolic Disturbances on Granulosa Cell Function and Follicular Development. Frontiers in Endocrinolo-gy, 13, Article 815968. [Google Scholar] [CrossRef] [PubMed]
[16] Van Gerwen, J., Shun-Shion, A.S. and Fazakerley, D.J. (2023) Insulin Signalling and GLUT4 Trafficking in Insulin Resistance. Biochemical Society Transactions, 51, 1057-1069. [Google Scholar] [CrossRef
[17] Xiang, S., Xia, M.F., Song, J. Y., et al. (2021) Effect of Elec-tro-Acupuncture on Expression of IRS-1/PI3K/GLUT4 Pathway in Ovarian Granulosa Cells of Infertile Patients with Polycystic Ovary Syndrome-Insulin Resistance of Phlegm-Dampness Syndrome. Chinese Journal of Integrative Medi-cine, 27, 330-335. [Google Scholar] [CrossRef] [PubMed]
[18] Zhang, H., Wang, W., Zhao, J., et al. (2023) Relationship between Body Composition, Insulin Resistance, and Hormonal Profiles in Women with Polycystic Ovary Syndrome. Frontiers in Endocrinology, 13, Article 1085656. [Google Scholar] [CrossRef] [PubMed]
[19] Huang, X., Wang, Q., Liu, T., et al. (2019) Body Fat Indices as Effective Predictors of Insulin Resistance in Obese/Non-Obese Polycystic Ovary Syndrome Women in the Southwest of China. Endocrine, 65, 81-85. [Google Scholar] [CrossRef] [PubMed]
[20] Erensoy, H., Niafar, M., Ghafarzadeh, S., et al. (2019) A Pilot Trial of Metformin for Insulin Resistance and Mood Disturbances in Adolescent and Adult Women with Polycystic Ovary Syndrome. Gynecological Endocrinology, 35, 72-75. [Google Scholar] [CrossRef] [PubMed]
[21] Oztas, E., Ozler, S., Tokmak, A., et al. (2016) Increased Levels of Serum Granzyme-B Is Associated with Insulin Resistance and Increased Cardiovascular Risk in Adolescent Polycystic Ovary Syndrome Patients. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 198, 89-93. [Google Scholar] [CrossRef] [PubMed]
[22] Brower, M., Brennan, K., Pall, M., et al. (2013) The Se-verity of Menstrual Dysfunction as a Predictor of Insulin Resistance in PCOS. The Journal of Clinical Endocrinology and Metabolism, 98, E1967-E1971. [Google Scholar] [CrossRef] [PubMed]
[23] Thong, E.P., Codner, E., Laven, J.S.E., et al. (2020) Diabetes: A Meta-bolic and Reproductive Disorder in Women. The Lancet Diabetes & Endocrinology, 8, 134-149. [Google Scholar] [CrossRef
[24] Jagannathan, R., Neves, J.S., Dorcely, B., et al. (2020) The Oral Glucose Tolerance Test: 100 Years Later. Diabetes, Metabolic Syndrome and Obesity, 13, 3787-3805. [Google Scholar] [CrossRef